Factory Promotional COVID-19 IgM test - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio


Product Detail

Product Tags

Related Video

Feedback (2)

We've got a specialist, effectiveness staff to supply high quality service for our shopper. We always follow the tenet of customer-oriented, details-focused for microbial test, aspergillus chemiluminescence, invasive cryptococcosis, We welcome customers all over the word to contact us for future business relationships. Our products are the best. Once Selected, Perfect Forever!
Factory Promotional COVID-19 IgM test - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio Detail:

Product Introduction

The Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) is an immunochromatographic test system intended for the qualitative detection of IMP-type carbapenemase in bacterial colonies. The assay is a prescription-use laboratory assay which can aid in the diagnosis of IMP-type carbapenem resistant strains.

Carbapenem-resistant NDM Detection K-Set (Lateral Flow Assay) 1

Characteristics

Name

Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay)

Method

Lateral Flow Assay

Sample type

Bacterial colonies

Specification

25 tests/kit

Detection time

10-15 min

Detection objects

Carbapenem-resistant Enterobacteriaceae (CRE)

Detection type

IMP

Stability

The K-Set is stable for 2 years at 2°C-30°C

Carbapenem-resistant IMP

Advantage

  • Rapid
    Obtain result within 15 min, 3 days earlier than traditional detection methods
  • Simple
    Easy to use, ordinary laboratory staff can operate without training
  • Accurate
    High sensitivity and specificity
    Low detection limit: 0.20 ng/mL
    Able to detect most of the common subtypes of IMP
  • Intuitive result
    There is no need for calculation, visual reading result
  • Economic
    Product can be transported and stored at room temperature, reducing costs

The importance of CRE test

Collectively, Enterobacterales are the most common group of pathogens causing healthcare-associated infections. Some Enterobacterales can produce an enzyme called a carbapenemase that makes antibiotics like carbapenems, penicillins, and cephalosporins ineffective. For this reason, CRE have been called “nightmare bacteria” because there are few alternative antibiotics, if any, left to treat the infections caused by these germs.

Bacteria from the Enterobacterales family, including Klebsiella species and Escherichia coli, can produce a carbapenemase. Carbapenemases are often produced from genes located on transferable elements that can spread resistance easily from germ to germ and person to person. Also because of the abuse usage of antibiotics and limited methods taken to prevent spreading, the dramatically increasing CRE problem is becoming a life threat worldwide.

Usually, spread of CRE can be controlled by:

  • Monitoring CRE infections
  • Isolate patients with CRE
  • Removing invasive medical devices inside the body
  • Be careful when prescribing antibiotics (especially carbapenems)
  • Using clean sterile techniques to minimize the spread of infection
  • Strictly follow the lab cleaning routine

……
CRE detection is of great value in spread control. By testing early, health providers can give a more reasonable therapy to patients susceptible to CRE, also achieve the hospitalization management.

IMP-type carbapenemase

Carbapenemase refers to a type of β-lactamase that can at least significantly hydrolyze imipenem or meropenem, including A, B, D three types of enzymes classified by Ambler molecular structure. Among them, Class B are metallo-β-lactamases (MBLs), including carbapenemases such as IMP, VIM and NDM,. IMP-type carbapenemase, also known as imipenemase metallo-beta-lactamase producing CRE, is a very common kind of acquired MBLs and is from subclass 3A. It can hydrolyze almost all β-lactam antibiotics.

Operation

  • Add 5 drops of sample treatment solution
  • Dip bacterial colonies with a disposable inoculation loop
  • Insert the loop into the tube
  • Add 50 μL to the S well, wait for 10-15 minutes
  • Read the result

Carbapenem-resistant KPC Detection K-Set (Lateral Flow Assay) 2

Order Information

Model

Description

Product code

CPI-01

25 tests/kit

CPI-01


Product detail pictures:

Factory Promotional COVID-19 IgM test - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio detail pictures


Related Product Guide:

With our leading technology at the same time as our spirit of innovation,mutual cooperation, benefits and growth, we're going to build a prosperous future together with your esteemed firm for Factory Promotional COVID-19 IgM test - Carbapenem-resistant IMP Detection K-Set (Lateral Flow Assay) – Genobio , The product will supply to all over the world, such as: Doha, luzern, Amsterdam, We are eager to cooperate with foreign companies which care much on the real quality, stable supply, strong capability and good service. We can offer the most competitive price with high quality,because we are much MORE PROFESSIONAL. You are welcomed to visit our company at any time.
  • It is a very good, very rare business partners, looking forward to the next more perfect cooperation!
    5 Stars By Lydia from Mauritius - 2018.06.28 19:27
    The company comply with the contract strict, a very reputable manufacturers, worthy a long-term cooperation.
    5 Stars By lucia from Singapore - 2017.08.15 12:36
    Write your message here and send it to us